Abstract
The protein truncation test (PTT) employs in vitro transcription and translation of amplified cDNA and exonic gDNA to reveal truncating germ-line mutations. In a series of PTT analyses, abnormal splicing in the region encompassing exons 20–23 of BRCA2 was discovered in leucocytes from high-risk breast cancer patients. Although sequencing of the genomic DNA in this region failed to reveal a detectable mutation in these patients, cDNA obtained from this region of BRCA2 uncovered numerous alternative splice isoforms. PTT analysis and nested RT-PCR using RNA from leucocytes from healthy individuals, normal tissue and breast and ovarian cancer tumours demonstrated the presence of these alternatively spliced transcripts in all cases. The splice forms appeared to be more prominent in RNA from aged blood, suggesting that isoform expression was conditional. It is therefore important to distinguish naturally occurring alternative splicing from true splice defects due to mutations when interpreting PTT results.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Wooster R, Bignell G, Lancaster J et al: Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789–792.
Collins N, McManus R, Wooster R et al: Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12–13. Oncogene 1995; 10: 1673–1675.
Gudmundsson J, Johannesdottir G, Bergthorsson JT et al: Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12–q13. Cancer Res 1995; 55: 4830–4832.
Wong AKC, Pero R, Ormonde PA, Tavtigian SV, Bartel PL : RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem 1997; 272: 31941–31944.
Marmorstein LY, Ouchi T, Aaronson SA : The BRCA2 gene product functionally interacts with p53 and RAD51. Proc Natl Acad Sci USA 1998; 95: 13869–13874.
Zou JP, Yoshinbu H, Siddique H, Rao VN, Reddy ESP : Structure and expression of variant BRCA2a lacking the transactivation domain. Oncol Rep 1999; 6: 437–440.
Bieche I, Lidereau R : Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumor breast tissue compared with normal tissue. Cancer Res 1999; 59: 2546–2550.
Hunt S : Human DNA sequence from clone RP1-214K23 on chromosome 13, containing BRCA2 gene. NCBI Entrez database 2001; gi|1929047|emb|Z74739.1|HS214K23 [1929047].
Garvin AM : A complete protein truncation test for BRCA1 and BRCA2. Eur J Hum Genet 1998; 6: 226–234.
Connor F, Bertwistle D, Mee PJ et al: Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat Genet 1997; 17: 423–430.
Spain BH, Larson CJ, Shihabuddin LS, Gage FH, Verma IM : BRCA2 is cytoplasmic: implications for cancer-linked mutations. Proc Natl Acad Sci USA 1999; 96: 13920–13925.
Yano K, Morotomi K, Saito H, Kato M, Matsuo F, Mini Y : Nuclear localization signals of the BRCA2 protein. Biochem Biophys Res Commun 2000; 270: 171–175.
Murtif-Park V, Kenwright KA, Surtevant DB, Karman Pivnick E : Alternative splicing of exons 29 and 30 in the neurofibromatosis type 1 gene. Hum Genet 1998; 103: 382–385.
Wimmer K, Eckart M, Rehder H, Fonatsch C : Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients. Hum Genet 2000; 106: 311–313.
Thomson SA, Wallace MR : RT-PCR splicing analysis of the NF1 open reading frame. Hum Genet 2002; 110: 495–502.
Flaman JM, Waridel F, Estreicher A et al: The human tumor suppressor gene p53 is alternatively spliced in normal cells. Oncogene 1996; 12: 813–818.
Sulekova Z, Reina-Sanchez J, Ballhausen WG : Multiple APC messenger RNA isoforms encoding exon 15 short open reading frames are expressed in the context of a novel exon 10A-derived sequence. Int J Cancer 1995; 63: 435–441.
Stoilov P, Meshorer E, Gencheva M, Glick D, Soreq H, Stamm S : Defects in pre-mRNA processing as causes of and predisposition to diseases. DNA Cell Biol 2002; 21: 803–818.
Acknowledgements
We thank RG Korneluk for his mentorship and support of SS Young and MD Speevak. We also thank M Fung Kee Fung and M Senterman for generously providing the ovarian tumour tissues.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Speevak, M., Young, S., Feilotter, H. et al. Alternatively spliced, truncated human BRCA2 isoforms contain a novel coding exon. Eur J Hum Genet 11, 951–954 (2003). https://doi.org/10.1038/sj.ejhg.5201063
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.ejhg.5201063
Keywords
This article is cited by
-
Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicing
Breast Cancer Research and Treatment (2011)
-
Caution should be taken in the methodology used to confirm c.156_157insAlu BRCA2 mutation
Breast Cancer Research and Treatment (2009)
